Back to 
Berkshire Hathaway Inc.
Berkshire Hathaway Inc.
ABBV
Showing 0 of 7 quarters
Position history for Berkshire Hathaway Inc.'s holdings in AbbVie Inc.
No. Berkshire Hathaway exited its ABBV (AbbVie) position in Q1 2022. Its Q4 2021 13F listed 3,033,561 shares worth $410.7M. Berkshire Hathaway first reported ABBV in Q3 2020 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.